Drug
Phenylephrine
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Premature Delivery | 100 | 30.7 | 31.4 | signal |
| 2 | Vitreous Floaters | 51 | 25.7 | 26.0 | signal |
| 3 | Cardiogenic Shock | 65 | 22.3 | 22.6 | signal |
| 4 | Premature Baby | 118 | 19.1 | 19.6 | signal |
| 5 | Metabolic Acidosis | 90 | 13.9 | 14.2 | signal |
| 6 | Respiratory Depression | 34 | 13.5 | 13.6 | signal |
| 7 | Serotonin Syndrome | 53 | 13.5 | 13.7 | signal |
| 8 | Bradycardia | 145 | 13.3 | 13.8 | signal |
| 9 | Shock | 60 | 12.8 | 13.0 | signal |
| 10 | Cardiomyopathy | 38 | 12.5 | 12.6 | signal |
| 11 | Maternal Exposure During Pregnancy | 216 | 12.0 | 12.5 | signal |
| 12 | Ventricular Fibrillation | 27 | 11.8 | 11.9 | signal |
| 13 | Posterior Reversible Encephalopathy Syndrome | 23 | 11.8 | 11.9 | signal |
| 14 | Drug Level Increased | 40 | 11.8 | 11.9 | signal |
| 15 | Circulatory Collapse | 41 | 11.7 | 11.8 | signal |
| 16 | Mydriasis | 30 | 11.4 | 11.5 | signal |
| 17 | Renal Tubular Necrosis | 23 | 11.4 | 11.5 | signal |
| 18 | Status Epilepticus | 26 | 11.2 | 11.3 | signal |
| 19 | Hypothermia | 23 | 11.1 | 11.1 | signal |
| 20 | Encephalopathy | 55 | 11.0 | 11.1 | signal |
| 21 | Hypoxia | 78 | 10.9 | 11.0 | signal |
| 22 | Hepatotoxicity | 48 | 10.6 | 10.7 | signal |
| 23 | Helicobacter Infection | 22 | 10.5 | 10.6 | signal |
| 24 | Exposure During Pregnancy | 132 | 10.4 | 10.7 | signal |
| 25 | Acute Respiratory Failure | 40 | 10.2 | 10.3 | signal |
| 26 | Lactic Acidosis | 66 | 10.0 | 10.2 | signal |
| 27 | Blood Calcium Decreased | 23 | 10.0 | 10.0 | signal |
| 28 | Multiple Organ Dysfunction Syndrome | 54 | 9.4 | 9.6 | signal |
| 29 | Hypotension | 379 | 9.2 | 10.0 | signal |
| 30 | Visual Acuity Reduced | 63 | 9.2 | 9.3 | signal |
| 31 | Mitral Valve Incompetence | 21 | 9.1 | 9.1 | signal |
| 32 | Cardiac Arrest | 149 | 8.8 | 9.1 | signal |
| 33 | Intentional Overdose | 112 | 8.6 | 8.8 | signal |
| 34 | Atelectasis | 17 | 8.6 | 8.6 | signal |
| 35 | Acute Respiratory Distress Syndrome | 31 | 8.6 | 8.6 | signal |
| 36 | Ventricular Tachycardia | 29 | 8.5 | 8.6 | signal |
| 37 | Foetal Exposure During Pregnancy | 136 | 8.2 | 8.4 | signal |
| 38 | Folliculitis | 17 | 8.0 | 8.1 | signal |
| 39 | Hand Deformity | 21 | 7.8 | 7.9 | signal |
| 40 | Bursitis | 19 | 7.7 | 7.7 | signal |
| 41 | Haemorrhage Intracranial | 23 | 7.5 | 7.5 | signal |
| 42 | Electrocardiogram Qt Prolonged | 55 | 7.5 | 7.5 | signal |
| 43 | Therapy Non-responder | 68 | 7.4 | 7.5 | signal |
| 44 | Depressed Level Of Consciousness | 60 | 7.4 | 7.5 | signal |
| 45 | Sinus Tachycardia | 21 | 7.2 | 7.3 | signal |
| 46 | Septic Shock | 63 | 7.1 | 7.2 | signal |
| 47 | Joint Range Of Motion Decreased | 19 | 6.9 | 7.0 | signal |
| 48 | Disseminated Intravascular Coagulation | 20 | 6.9 | 6.9 | signal |
| 49 | Ejection Fraction Decreased | 22 | 6.9 | 6.9 | signal |
| 50 | Pulmonary Oedema | 62 | 6.7 | 6.8 | signal |
| 51 | Pemphigus | 16 | 6.3 | 6.3 | signal |
| 52 | Respiratory Failure | 92 | 6.2 | 6.3 | signal |
| 53 | Acute Hepatic Failure | 17 | 6.1 | 6.1 | signal |
| 54 | Myocardial Ischaemia | 14 | 6.0 | 6.0 | signal |
| 55 | Retinal Detachment | 11 | 5.8 | 5.8 | signal |
| 56 | Wound Infection | 13 | 5.8 | 5.8 | signal |
| 57 | Post Procedural Complication | 23 | 5.8 | 5.9 | signal |
| 58 | Bronchospasm | 17 | 5.8 | 5.8 | signal |
| 59 | Tachycardia | 105 | 5.8 | 5.9 | signal |
| 60 | Intraocular Pressure Increased | 15 | 5.7 | 5.7 | signal |
| 61 | Eye Inflammation | 11 | 5.7 | 5.7 | signal |
| 62 | Pneumonia Aspiration | 29 | 5.7 | 5.7 | signal |
| 63 | Acute Kidney Injury | 177 | 5.7 | 5.9 | signal |
| 64 | Generalised Tonic-clonic Seizure | 18 | 5.4 | 5.4 | signal |
| 65 | Feeling Jittery | 21 | 5.4 | 5.4 | signal |
| 66 | Brain Injury | 11 | 5.3 | 5.4 | signal |
| 67 | Multi-organ Failure | 19 | 5.3 | 5.3 | signal |
| 68 | Joint Injury | 23 | 5.2 | 5.3 | signal |
| 69 | Photophobia | 20 | 5.2 | 5.2 | signal |
| 70 | Incorrect Route Of Product Administration | 18 | 5.2 | 5.2 | signal |
| 71 | Schizophrenia | 13 | 5.2 | 5.2 | signal |
| 72 | Deformity | 10 | 5.2 | 5.2 | signal |
| 73 | Leukocytosis | 19 | 5.1 | 5.1 | signal |
| 74 | Hypercholesterolaemia | 10 | 5.1 | 5.1 | signal |
| 75 | Anaphylactic Reaction | 57 | 5.1 | 5.1 | signal |
| 76 | Sinus Bradycardia | 10 | 5.0 | 5.0 | signal |
| 77 | End Stage Renal Disease | 19 | 5.0 | 5.0 | signal |
| 78 | Post Procedural Haemorrhage | 12 | 5.0 | 5.0 | signal |
| 79 | Pericarditis | 17 | 5.0 | 5.0 | signal |
| 80 | Acute Myocardial Infarction | 30 | 4.9 | 5.0 | signal |
| 81 | Delirium | 35 | 4.9 | 5.0 | signal |
| 82 | Mental Status Changes | 28 | 4.9 | 4.9 | signal |
| 83 | Unresponsive To Stimuli | 25 | 4.7 | 4.8 | signal |
| 84 | Drug Ineffective For Unapproved Indication | 54 | 4.7 | 4.8 | signal |
| 85 | Flank Pain | 9 | 4.7 | 4.7 | signal |
| 86 | Liver Injury | 23 | 4.6 | 4.7 | signal |
| 87 | Autoimmune Disorder | 9 | 4.6 | 4.6 | signal |
| 88 | Toxic Epidermal Necrolysis | 14 | 4.5 | 4.5 | signal |
| 89 | Fibromyalgia | 22 | 4.4 | 4.4 | signal |
| 90 | Coagulopathy | 15 | 4.4 | 4.4 | signal |
| 91 | Drug Interaction | 143 | 4.4 | 4.5 | signal |
| 92 | Hypertensive Crisis | 10 | 4.4 | 4.4 | signal |
| 93 | Contraindicated Product Administered | 27 | 4.4 | 4.4 | signal |
| 94 | Ileus | 11 | 4.4 | 4.4 | signal |
| 95 | Fluid Overload | 13 | 4.3 | 4.3 | signal |
| 96 | Obesity | 14 | 4.3 | 4.3 | signal |
| 97 | Tenderness | 9 | 4.2 | 4.2 | signal |
| 98 | Type 2 Diabetes Mellitus | 29 | 4.2 | 4.2 | signal |
| 99 | Caesarean Section | 10 | 4.1 | 4.2 | signal |
| 100 | Glossodynia | 19 | 4.1 | 4.2 | signal |
| 101 | Cytokine Release Syndrome | 16 | 4.1 | 4.1 | signal |
| 102 | Supraventricular Tachycardia | 8 | 4.1 | 4.1 | signal |
| 103 | Eye Pain | 45 | 4.0 | 4.0 | signal |
| 104 | Tachypnoea | 11 | 4.0 | 4.0 | signal |
| 105 | Therapeutic Product Effect Decreased | 36 | 4.0 | 4.0 | signal |
| 106 | Cardiomegaly | 10 | 3.9 | 3.9 | signal |
| 107 | Intestinal Perforation | 9 | 3.9 | 3.9 | signal |
| 108 | Renal Injury | 24 | 3.9 | 3.9 | signal |
| 109 | Liver Function Test Increased | 17 | 3.9 | 3.9 | signal |
| 110 | Toxicity To Various Agents | 133 | 3.9 | 4.0 | signal |
| 111 | Anaphylactic Shock | 20 | 3.8 | 3.8 | signal |
| 112 | Coma | 37 | 3.8 | 3.8 | signal |
| 113 | Synovitis | 14 | 3.8 | 3.8 | signal |
| 114 | Blood Bilirubin Increased | 21 | 3.8 | 3.8 | signal |
| 115 | Pallor | 21 | 3.8 | 3.8 | signal |
| 116 | Rash Maculo-papular | 17 | 3.7 | 3.8 | signal |
| 117 | Nodule | 10 | 3.7 | 3.7 | signal |
| 118 | Pulmonary Hypertension | 16 | 3.7 | 3.7 | signal |
| 119 | Hemiparesis | 13 | 3.7 | 3.7 | signal |
| 120 | Joint Stiffness | 20 | 3.7 | 3.7 | signal |
| 121 | Macular Degeneration | 9 | 3.7 | 3.7 | signal |
| 122 | Tubulointerstitial Nephritis | 14 | 3.6 | 3.7 | signal |
| 123 | No Therapeutic Response | 9 | 3.5 | 3.6 | signal |
| 124 | Product Preparation Error | 15 | 3.5 | 3.5 | signal |
| 125 | Blood Pressure Decreased | 48 | 3.5 | 3.6 | signal |
| 126 | Hyperkalaemia | 25 | 3.5 | 3.5 | signal |
| 127 | Brain Oedema | 9 | 3.5 | 3.5 | signal |
| 128 | Blindness Unilateral | 10 | 3.5 | 3.5 | signal |
| 129 | Product Use Complaint | 11 | 3.5 | 3.5 | signal |
| 130 | Irritable Bowel Syndrome | 15 | 3.4 | 3.4 | signal |
| 131 | Renal Failure Acute | 30 | 3.4 | 3.4 | signal |
| 132 | Cerebral Infarction | 17 | 3.4 | 3.4 | signal |
| 133 | Sciatica | 11 | 3.4 | 3.4 | signal |
| 134 | Blindness | 28 | 3.4 | 3.4 | signal |
| 135 | Subarachnoid Haemorrhage | 7 | 3.3 | 3.3 | signal |
| 136 | Ear Discomfort | 7 | 3.3 | 3.3 | signal |
| 137 | Musculoskeletal Pain | 36 | 3.3 | 3.3 | signal |
| 138 | Ataxia | 8 | 3.3 | 3.3 | signal |
| 139 | Myoclonus | 8 | 3.3 | 3.3 | signal |
| 140 | Quality Of Life Decreased | 9 | 3.3 | 3.3 | signal |
| 141 | Uveitis | 9 | 3.2 | 3.3 | signal |
| 142 | Cardio-respiratory Arrest | 28 | 3.2 | 3.3 | signal |
| 143 | International Normalised Ratio Increased | 19 | 3.2 | 3.2 | signal |
| 144 | Renal Failure | 88 | 3.2 | 3.3 | signal |
| 145 | Generalised Oedema | 8 | 3.2 | 3.2 | signal |
| 146 | Wound | 18 | 3.2 | 3.2 | signal |
| 147 | Seizure | 74 | 3.1 | 3.2 | signal |
| 148 | Wheezing | 38 | 3.1 | 3.2 | signal |
| 149 | Nephropathy Toxic | 7 | 3.1 | 3.1 | signal |
| 150 | Fear | 17 | 3.1 | 3.1 | signal |
| 151 | Obstructive Airways Disorder | 7 | 3.1 | 3.1 | signal |
| 152 | Systemic Lupus Erythematosus | 22 | 3.0 | 3.0 | signal |
| 153 | Renal Impairment | 51 | 3.0 | 3.0 | signal |
| 154 | Treatment Failure | 49 | 2.9 | 2.9 | signal |
| 155 | Vision Blurred | 81 | 2.9 | 2.9 | signal |
| 156 | Arthropathy | 33 | 2.9 | 2.9 | signal |
| 157 | Eyelid Ptosis | 6 | 2.9 | 2.9 | signal |
| 158 | Eye Discharge | 6 | 2.9 | 2.9 | signal |
| 159 | Muscle Rigidity | 7 | 2.9 | 2.9 | signal |
| 160 | Hyperbilirubinaemia | 6 | 2.8 | 2.8 | signal |
| 161 | Skin Ulcer | 15 | 2.8 | 2.8 | signal |
| 162 | Impaired Healing | 19 | 2.8 | 2.8 | signal |
| 163 | Neuralgia | 14 | 2.8 | 2.8 | signal |
| 164 | Rhabdomyolysis | 24 | 2.8 | 2.8 | signal |
| 165 | Accidental Overdose | 21 | 2.8 | 2.8 | signal |
| 166 | Chronic Kidney Disease | 44 | 2.8 | 2.8 | signal |
| 167 | Dialysis | 8 | 2.7 | 2.7 | signal |
| 168 | Subdural Haematoma | 8 | 2.7 | 2.7 | signal |
| 169 | Paralysis | 8 | 2.7 | 2.7 | signal |
| 170 | Disability | 11 | 2.7 | 2.7 | signal |
| 171 | Back Injury | 6 | 2.7 | 2.7 | signal |
| 172 | Ocular Discomfort | 6 | 2.7 | 2.7 | signal |
| 173 | Conjunctivitis | 10 | 2.7 | 2.7 | signal |
| 174 | Angioedema | 24 | 2.7 | 2.7 | signal |
| 175 | Heart Rate Decreased | 19 | 2.6 | 2.6 | signal |
| 176 | Haematoma | 14 | 2.6 | 2.6 | signal |
| 177 | Therapeutic Product Effect Incomplete | 38 | 2.6 | 2.6 | signal |
| 178 | Poisoning Deliberate | 5 | 2.6 | 2.6 | no signal |
| 179 | Dry Eye | 26 | 2.6 | 2.6 | signal |
| 180 | Chromaturia | 12 | 2.6 | 2.6 | signal |
| 181 | Hepatic Failure | 16 | 2.6 | 2.6 | signal |
| 182 | Anhedonia | 14 | 2.6 | 2.6 | signal |
| 183 | Suicide Attempt | 32 | 2.6 | 2.6 | signal |
| 184 | Injury | 37 | 2.6 | 2.6 | signal |
| 185 | Eye Haemorrhage | 7 | 2.6 | 2.6 | signal |
| 186 | Economic Problem | 8 | 2.5 | 2.5 | signal |
| 187 | Neurotoxicity | 9 | 2.5 | 2.5 | signal |
| 188 | Drug Dispensing Error | 8 | 2.5 | 2.5 | signal |
| 189 | Cyanosis | 8 | 2.5 | 2.5 | signal |
| 190 | Drug Toxicity | 7 | 2.5 | 2.5 | signal |
| 191 | Inflammation | 26 | 2.5 | 2.5 | signal |
| 192 | Ischaemic Stroke | 9 | 2.5 | 2.5 | signal |
| 193 | Cerebral Haemorrhage | 18 | 2.5 | 2.5 | signal |
| 194 | Drug Ineffective | 662 | 2.5 | 2.7 | signal |
| 195 | Ulcer | 8 | 2.4 | 2.5 | signal |
| 196 | Glomerular Filtration Rate Decreased | 6 | 2.4 | 2.4 | no signal |
| 197 | Transaminases Increased | 11 | 2.4 | 2.4 | signal |
| 198 | Hypoglycaemia | 24 | 2.4 | 2.4 | signal |
| 199 | Motor Dysfunction | 5 | 2.4 | 2.4 | no signal |
| 200 | Ocular Hyperaemia | 23 | 2.4 | 2.4 | signal |
| 201 | Cataract | 29 | 2.4 | 2.4 | signal |
| 202 | Cholelithiasis | 16 | 2.4 | 2.4 | signal |
| 203 | Impaired Quality Of Life | 7 | 2.4 | 2.4 | signal |
| 204 | Drug-induced Liver Injury | 15 | 2.4 | 2.4 | signal |
| 205 | Psychotic Disorder | 14 | 2.3 | 2.3 | signal |
| 206 | Haematemesis | 12 | 2.3 | 2.3 | signal |
| 207 | Visual Impairment | 58 | 2.3 | 2.3 | signal |
| 208 | Infusion Related Reaction | 31 | 2.3 | 2.3 | signal |
| 209 | Lacrimation Increased | 14 | 2.3 | 2.3 | signal |
| 210 | Musculoskeletal Stiffness | 41 | 2.3 | 2.3 | signal |
| 211 | Impaired Work Ability | 10 | 2.3 | 2.3 | signal |
| 212 | Prescribed Overdose | 9 | 2.3 | 2.3 | signal |
| 213 | Nerve Injury | 5 | 2.2 | 2.2 | no signal |
| 214 | Blood Creatine Phosphokinase Increased | 13 | 2.2 | 2.2 | signal |
| 215 | Lung Infection | 7 | 2.2 | 2.2 | no signal |
| 216 | Gastric Haemorrhage | 5 | 2.1 | 2.1 | no signal |
| 217 | Product Packaging Issue | 4 | 2.1 | 2.1 | no signal |
| 218 | Eye Irritation | 24 | 2.1 | 2.1 | signal |
| 219 | Eyelid Oedema | 5 | 2.1 | 2.1 | no signal |
| 220 | Overdose | 90 | 2.0 | 2.0 | signal |
| 221 | Coeliac Disease | 4 | 2.0 | 2.0 | no signal |
| 222 | Product Administration Error | 8 | 2.0 | 2.0 | no signal |
| 223 | Medication Error | 22 | 1.9 | 1.9 | no signal |
| 224 | Toxic Skin Eruption | 4 | 1.9 | 1.9 | no signal |
| 225 | Neoplasm Malignant | 26 | 1.9 | 1.9 | no signal |
| 226 | Pelvic Pain | 7 | 1.9 | 1.9 | no signal |
| 227 | Road Traffic Accident | 16 | 1.9 | 1.9 | no signal |
| 228 | Bone Density Decreased | 12 | 1.8 | 1.8 | no signal |
| 229 | Adverse Reaction | 5 | 1.8 | 1.8 | no signal |
| 230 | Product Dispensing Error | 8 | 1.8 | 1.8 | no signal |
| 231 | Eye Pruritus | 12 | 1.8 | 1.8 | no signal |
| 232 | Respiratory Arrest | 10 | 1.8 | 1.8 | no signal |
| 233 | Device Occlusion | 5 | 1.8 | 1.8 | no signal |
| 234 | Psoriatic Arthropathy | 14 | 1.7 | 1.7 | no signal |
| 235 | Sedation | 9 | 1.7 | 1.7 | no signal |
| 236 | Product Prescribing Issue | 7 | 1.7 | 1.7 | no signal |
| 237 | Polyneuropathy | 4 | 1.6 | 1.6 | no signal |
| 238 | Cytopenia | 4 | 1.6 | 1.6 | no signal |
| 239 | Blood Thyroid Stimulating Hormone Increased | 3 | 1.6 | 1.6 | no signal |
| 240 | Drug Exposure During Pregnancy | 11 | 1.6 | 1.6 | no signal |
| 241 | Erectile Dysfunction | 8 | 1.5 | 1.5 | no signal |
| 242 | Complication Associated With Device | 4 | 1.5 | 1.5 | no signal |
| 243 | Convulsion | 17 | 1.4 | 1.4 | no signal |
| 244 | Lung Neoplasm Malignant | 12 | 1.4 | 1.4 | no signal |
| 245 | Central Nervous System Lesion | 4 | 1.4 | 1.4 | no signal |
| 246 | Prostatic Specific Antigen Increased | 4 | 1.4 | 1.4 | no signal |
| 247 | Emotional Distress | 35 | 1.4 | 1.4 | no signal |
| 248 | Rheumatoid Arthritis | 32 | 1.4 | 1.4 | no signal |
| 249 | Dystonia | 5 | 1.3 | 1.3 | no signal |
| 250 | Sleep Disorder Due To A General Medical Condition | 4 | 1.2 | 1.2 | no signal |
| 251 | Peritonitis | 5 | 1.2 | 1.2 | no signal |
| 252 | Expired Product Administered | 8 | 1.2 | 1.2 | no signal |
| 253 | Myocardial Infarction | 42 | 1.2 | 1.2 | no signal |
| 254 | Poisoning | 3 | 1.2 | 1.2 | no signal |
| 255 | Product Quality Issue | 31 | 1.1 | 1.1 | no signal |
| 256 | Device Delivery System Issue | 6 | 1.1 | 1.1 | no signal |
| 257 | Circumstance Or Information Capable Of Leading To Medication Error | 7 | 1.0 | 1.0 | no signal |
| 258 | Device Failure | 3 | 1.0 | 1.0 | no signal |
| 259 | Pregnancy | 4 | 1.0 | 1.0 | no signal |
| 260 | Incorrect Route Of Drug Administration | 7 | 0.9 | 0.9 | no signal |
| 261 | Completed Suicide | 15 | 0.9 | 0.9 | no signal |
| 262 | Drug Effective For Unapproved Indication | 5 | 0.8 | 0.8 | no signal |
| 263 | Extra Dose Administered | 6 | 0.7 | 0.7 | no signal |
| 264 | Intentional Self-injury | 3 | 0.7 | 0.7 | no signal |
| 265 | Drug Abuse | 12 | 0.7 | 0.7 | no signal |
| 266 | Incorrect Dose Administered By Device | 3 | 0.6 | 0.6 | no signal |
| 267 | Drug Withdrawal Syndrome | 10 | 0.5 | 0.5 | no signal |
| 268 | Accidental Exposure To Product | 10 | 0.5 | 0.5 | no signal |